Toshiyuki Kita
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Toshiyuki Kita has a total of 341 co-authors. Here are the top co-authors by number of shared publications:
Masaki Fujimura
22 shared publicationsShinji Nakao
17 shared publicationsKazuo Kasahara
Department of Respiratory Medicine, Kanazawa University Hospital, Kanazawa, Ishikawa, Japan
15 shared publications- Tomoyuki Araya
Department of Respiratory Medicine NHO Kanazawa Medical Center Kanazawa Ishikawa Japan
13 shared publications Shigeharu Myou
11 shared publicationsHideharu Kimura
Department of Respiratory Medicine, Kanazawa University Hospital, Kanazawa, Japan
8 shared publications
Latest Publications
- Open Access
- 11 September 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (18) , 7038
Low Body Mass Index Is Associated with a Long-Term Decline in Accelerometer-Measured Physical Activity in Patients with COPD: An Exploratory Analysis of Participants Co-Enrolled in Two Prospective Cohort Studies
Background/Objectives: Reduced physical activity (PA) and increased sedentary behavior (SB) are associated with adverse outcomes in chronic obstructive pulmonary disease (COPD), but the factors underlying their long-term change are unclear; we investigated the baseline factors associated with these changes. Methods: Japanese outpatients with stable COPD co-enrolled in the SPACE (baseline) and E-PAC (follow-up) studies were analyzed retrospectively. Twenty-nine baseline clinical variables were assessed. PA and SB were measured with a waist-worn triaxial accelerometer and expressed in metabolic equivalents (METs). Annualized percentage changes (per year, relative to baseline) were analyzed by Spearman’s rank correlation and multiple linear regression. Results: Thirty-two participants (all men; median age 71.0 years; median follow-up 5.0 years) were analyzed. Lower baseline body weight, BMI, upper arm circumference, FEV1.0, FEV1.0/FVC, and lowest percutaneous oxygen saturation (SpO2) during the 6 min walk test (6MWT) were correlated with greater annualized declines in PA. For SB, the annualized change was correlated only with the lowest SpO2 during the 6MWT, FEV1.0/FVC, and the hemoglobin concentration. In multivariable models adjusted for FEV1.0 %pred and the lowest SpO2 during the 6MWT, BMI remained associated with the declines in total PA and in the duration at ≥3.0 METs; the models for the step count and SB were not significant. Conclusions: In this exploratory analysis, nutrition-related anthropometric measures, poorer pulmonary function, and exercise-induced desaturation were associated with the long-term decline in PA, and a lower BMI remained associated after adjustment. For the change in SB, associations were found only in unadjusted correlation analysis and were not supported by the multivariable model. These hypothesis-generating findings require confirmation in a larger cohort.
- 11 September 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (18) , 7038
Open AccessLow Body Mass Index Is Associated with a Long-Term Decline in Accelerometer-Measured Physical Activity in Patients with COPD: An Exploratory Analysis of Participants Co-Enrolled in Two Prospective Cohort Studies
Background/Objectives: Reduced physical activity (PA) and increased sedentary behavior (SB) are associated with adverse outcomes in chronic obstructive pulmonary disease (COPD), but the factors underlying their long-term change are unclear; we investigated the baseline factors associated with these changes. Methods: Japanese outpatients with stable COPD co-enrolled in the SPACE (baseline) and E-PAC (follow-up) studies were analyzed retrospectively. Twenty-nine baseline clinical variables were assessed. PA and SB were measured with a waist-worn triaxial accelerometer and expressed in metabolic equivalents (METs). Annualized percentage changes (per year, relative to baseline) were analyzed by Spearman’s rank correlation and multiple linear regression. Results: Thirty-two participants (all men; median age 71.0 years; median follow-up 5.0 years) were analyzed. Lower baseline body weight, BMI, upper arm circumference, FEV1.0, FEV1.0/FVC, and lowest percutaneous oxygen saturation (SpO2) during the 6 min walk test (6MWT) were correlated with greater annualized declines in PA. For SB, the annualized change was correlated only with the lowest SpO2 during the 6MWT, FEV1.0/FVC, and the hemoglobin concentration. In multivariable models adjusted for FEV1.0 %pred and the lowest SpO2 during the 6MWT, BMI remained associated with the declines in total PA and in the duration at ≥3.0 METs; the models for the step count and SB were not significant. Conclusions: In this exploratory analysis, nutrition-related anthropometric measures, poorer pulmonary function, and exercise-induced desaturation were associated with the long-term decline in PA, and a lower BMI remained associated after adjustment. For the change in SB, associations were found only in unadjusted correlation analysis and were not supported by the multivariable model. These hypothesis-generating findings require confirmation in a larger cohort.
- Open Access
- 19 August 2026
- Published by MDPI AG in Preprints.org
Low Body Mass Index Is Associated with a 5-Year Decline in Accelerometer-Measured Physical Activity in Patients with COPD
Background/Objectives: Reduced physical activity (PA) and increased sedentary behavior (SB) are associated with adverse outcomes in chronic obstructive pulmonary disease (COPD). However, the factors associated with their long-term change remain unclear. We investigated the baseline factors associated with a longitudinal decline in PA and increase in SB. Methods: Stable outpatients with COPD who participated in both the SPACE (baseline) and E-PAC (follow-up) studies in Japan were analyzed retrospectively. At baseline, 29 clinical variables were assessed, including demographic and anthropometric data, nutritional indices (body mass index [BMI], upper arm circumference), pulmonary function, blood tests, and the lowest percutaneous oxygen saturation (SpO2) during the 6-min walk test (6MWT). PA and SB were measured with a waist-worn triaxial accelerometer and expressed in metabolic equivalents (METs). Annual percentage changes were analyzed using Spearman’s rank correlation and multiple linear regression. Analyses were exploratory, with 95% confidence intervals reported. Results: Thirty-two men (median age 71.0 years; median follow-up 5.0 years) were analyzed. Greater annual declines in PA were associated with a poorer baseline nutritional status (lower body weight, BMI, and upper arm circumference), lower pulmonary function, and a lower lowest SpO2 during the 6MWT (i.e., exercise-induced desaturation). A greater annual increase in SB was associated with a lower lowest SpO2 and a higher baseline hemoglobin concentration. In multivariable models, BMI remained independently associated with the declines in total PA and in the duration at ≥3.0 METs. Conclusions: In this exploratory analysis, nutritional status, pulmonary function, and exercise-induced desaturation were associated with long-term behavioral changes in COPD, with BMI showing the most consistent association with the decline in PA. These hypothesis-generating findings require confirmation in a larger cohort.
- 19 August 2026
- Published by MDPI AG in Preprints.org
Open AccessLow Body Mass Index Is Associated with a 5-Year Decline in Accelerometer-Measured Physical Activity in Patients with COPD
Background/Objectives: Reduced physical activity (PA) and increased sedentary behavior (SB) are associated with adverse outcomes in chronic obstructive pulmonary disease (COPD). However, the factors associated with their long-term change remain unclear. We investigated the baseline factors associated with a longitudinal decline in PA and increase in SB. Methods: Stable outpatients with COPD who participated in both the SPACE (baseline) and E-PAC (follow-up) studies in Japan were analyzed retrospectively. At baseline, 29 clinical variables were assessed, including demographic and anthropometric data, nutritional indices (body mass index [BMI], upper arm circumference), pulmonary function, blood tests, and the lowest percutaneous oxygen saturation (SpO2) during the 6-min walk test (6MWT). PA and SB were measured with a waist-worn triaxial accelerometer and expressed in metabolic equivalents (METs). Annual percentage changes were analyzed using Spearman’s rank correlation and multiple linear regression. Analyses were exploratory, with 95% confidence intervals reported. Results: Thirty-two men (median age 71.0 years; median follow-up 5.0 years) were analyzed. Greater annual declines in PA were associated with a poorer baseline nutritional status (lower body weight, BMI, and upper arm circumference), lower pulmonary function, and a lower lowest SpO2 during the 6MWT (i.e., exercise-induced desaturation). A greater annual increase in SB was associated with a lower lowest SpO2 and a higher baseline hemoglobin concentration. In multivariable models, BMI remained independently associated with the declines in total PA and in the duration at ≥3.0 METs. Conclusions: In this exploratory analysis, nutritional status, pulmonary function, and exercise-induced desaturation were associated with long-term behavioral changes in COPD, with BMI showing the most consistent association with the decline in PA. These hypothesis-generating findings require confirmation in a larger cohort.
- Open Access
- 21 April 2026
- Published by Wiley in Respirology Case Reports
- Vol. 14 (4) , e70588
Positron Emission Tomography‐Negative Mediastinal Lymph Node Metastasis From Clear Cell Renal Cell Carcinoma 11 Years After Nephrectomy Diagnosed by Endobronchial Ultrasound‐Guided Transbronchial Needle Capillary Sampling
A 73‐year‐old man was referred for evaluation of mediastinal lymphadenopathy. He had undergone right nephrectomy for clear cell renal cell carcinoma (ccRCC; pT3aN0M0, stage III) 11 years earlier and had remained recurrence‐free without adjuvant therapy. Positron emission tomography/computed tomography (PET/CT) revealed an enlarged subcarinal lymph node which was non‐FDG avid. Bronchoscopy was performed to obtain a pathological diagnosis. Endobronchial ultrasound‐guided transbronchial needle aspiration (EBUS‐TBNA) initially yielded bloody and inadequate specimens on rapid on‐site cytologic evaluation (ROSE). The sampling technique was therefore switched to endobronchial ultrasound‐guided transbronchial needle capillary sampling (EBUS‐TBNCS), and ROSE demonstrated adequate cellular material with atypical cells. Histopathology and immunohistochemistry confirmed metastatic ccRCC. This case highlights that metastatic ccRCC should be considered in PET‐negative mediastinal lymphadenopathy more than a decade after nephrectomy and that EBUS‐TBNCS may facilitate diagnostic tissue acquisition when conventional EBUS‐TBNA yields bloody specimens.
- 21 April 2026
- Published by Wiley in Respirology Case Reports
- Vol. 14 (4) , e70588
Open AccessPositron Emission Tomography‐Negative Mediastinal Lymph Node Metastasis From Clear Cell Renal Cell Carcinoma 11 Years After Nephrectomy Diagnosed by Endobronchial Ultrasound‐Guided Transbronchial Needle Capillary Sampling
A 73‐year‐old man was referred for evaluation of mediastinal lymphadenopathy. He had undergone right nephrectomy for clear cell renal cell carcinoma (ccRCC; pT3aN0M0, stage III) 11 years earlier and had remained recurrence‐free without adjuvant therapy. Positron emission tomography/computed tomography (PET/CT) revealed an enlarged subcarinal lymph node which was non‐FDG avid. Bronchoscopy was performed to obtain a pathological diagnosis. Endobronchial ultrasound‐guided transbronchial needle aspiration (EBUS‐TBNA) initially yielded bloody and inadequate specimens on rapid on‐site cytologic evaluation (ROSE). The sampling technique was therefore switched to endobronchial ultrasound‐guided transbronchial needle capillary sampling (EBUS‐TBNCS), and ROSE demonstrated adequate cellular material with atypical cells. Histopathology and immunohistochemistry confirmed metastatic ccRCC. This case highlights that metastatic ccRCC should be considered in PET‐negative mediastinal lymphadenopathy more than a decade after nephrectomy and that EBUS‐TBNCS may facilitate diagnostic tissue acquisition when conventional EBUS‐TBNA yields bloody specimens.
- Open Access
- 20 January 2026
- Published by Wiley in Respirology Case Reports
- Vol. 14 (1)
Extensive Lymphadenopathy in an HIV ‐Negative Patient With Multidrug‐Resistant Tuberculosis
Tuberculous lymphadenitis is generally more severe in patients with HIV infection. We present an HIV‐negative patient with multidrug‐resistant tuberculosis who developed severe, extensive lymphadenitis involving multiple extrapulmonary regions. This clinical image highlights that marked lymph node involvement may occur in HIV‐negative patients presenting with pronounced systemic symptoms.
- 20 January 2026
- Published by Wiley in Respirology Case Reports
- Vol. 14 (1)
Open AccessExtensive Lymphadenopathy in an HIV ‐Negative Patient With Multidrug‐Resistant Tuberculosis
Tuberculous lymphadenitis is generally more severe in patients with HIV infection. We present an HIV‐negative patient with multidrug‐resistant tuberculosis who developed severe, extensive lymphadenitis involving multiple extrapulmonary regions. This clinical image highlights that marked lymph node involvement may occur in HIV‐negative patients presenting with pronounced systemic symptoms.
- Open Access
- 19 January 2026
- Published by Elsevier in Respiratory Investigation
- Vol. 64 (2) , 101361
Oxygenation deterioration and computed tomography findings in acute exacerbation of interstitial lung diseases: a prospective observational study
- 19 January 2026
- Published by Elsevier in Respiratory Investigation
- Vol. 64 (2) , 101361
Open AccessOxygenation deterioration and computed tomography findings in acute exacerbation of interstitial lung diseases: a prospective observational study
- Open Access
- 19 January 2026
- Published by Wiley in Respirology Case Reports
- Vol. 14 (1)
Severe Lung Abscess and Sepsis Caused by Klebsiella ozaenae in a Malnourished Patient With Psychiatric Disease
Severe infections caused by Klebsiella ozaenae are extremely rare, and their clinical characteristics remain poorly defined. We report a case of Klebsiella ozaenae sepsis with severe lung abscesses in a malnourished patient with psychiatric disease, requiring 3 months of antimicrobial therapy for complete resolution.
- 19 January 2026
- Published by Wiley in Respirology Case Reports
- Vol. 14 (1)
Open AccessSevere Lung Abscess and Sepsis Caused by Klebsiella ozaenae in a Malnourished Patient With Psychiatric Disease
Severe infections caused by Klebsiella ozaenae are extremely rare, and their clinical characteristics remain poorly defined. We report a case of Klebsiella ozaenae sepsis with severe lung abscesses in a malnourished patient with psychiatric disease, requiring 3 months of antimicrobial therapy for complete resolution.
- 31 December 2025
- Published by Elsevier in Respiratory Medicine
- Vol. 252, 108629
Anti-MDA5 antibody-positive interstitial lung disease without prominent skin or muscle manifestations: A high-risk and potentially overlooked subgroup
- 31 December 2025
- Published by Elsevier in Respiratory Medicine
- Vol. 252, 108629
Anti-MDA5 antibody-positive interstitial lung disease without prominent skin or muscle manifestations: A high-risk and potentially overlooked subgroup
- Open Access
- 1 August 2025
- Published by Oxford University Press (OUP) in Annals of the American Thoracic Society
- Vol. 22 (8) , 1183-1192
Intermittent Versus Daily Therapy for Noncavitary Mycobacterium avium Complex Pulmonary Disease: An Open-Label Randomized Trial
Rationale: Patients with noncavitary nodular bronchiectatic (NB) Mycobacterium avium complex pulmonary disease (MAC-PD) are treated intermittently three times per week, although no randomized controlled trials have been conducted comparing three times weekly with daily therapy. Objectives: To assess the tolerability, safety, and efficacy of intermittent versus daily treatment in patients with previously untreated noncavitary NB MAC-PD. Methods: In an open-label study, patients were randomly assigned to the intermittent therapy group receiving clarithromycin 1,000 mg, rifampicin 600 mg, and ethambutol 25 mg/kg (maximum 1,000 mg) three days per week or the daily therapy group receiving clarithromycin 800 mg, rifampicin 450 mg, and ethambutol 15 mg/kg (maximum 750 mg) daily for 1 year. The primary endpoint was the proportion of patients requiring modification of the initial treatment regimen. Results: Twenty-one Japanese hospitals participated in the study, enrolling 141 patients between May 2019 and December 2021. The full analysis set included 138 participants (intermittent therapy = 70; daily therapy = 68). There were no significant differences between the intermittent and daily therapy groups in terms of the regimen modification rate (20.0% [14 of 70] vs. 33.8% [23 of 68]; adjusted odds ratio, 0.48; 95% confidence interval, 0.22 to 1.05; P = 0.06) or culture conversion (70.3% vs. 80.0%; P = 0.53), time to culture conversion (28.0 vs. 28.5 d; P = 0.89), improvement in chest CT findings (60.9% vs. 71.0%; P = 0.30), or clarithromycin resistance development (1.4% vs. 0%; P = 1.00). Elevated aspartate aminotransferase (16.9% vs. 41.2%; P = 0.003) and alanine aminotransferase (18.3% vs. 44.1%; P = 0.002) were more common in the daily treatment group, whereas elevated bilirubin (11.3% vs. 1.5%; P = 0.04) and dysgeusia (14.1% vs. 1.5%; P = 0.01) were more common in the intermittent treatment group. The daily treatment group exhibited a greater absolute change in the 36-Item Short Form Health Survey physical aspect score (−2.5 points) than the intermittent treatment group (2.1 points) (P = 0.01). Conclusions: Intermittent treatment was not significantly better tolerated than daily treatment for noncavitary NB MAC-PD. However, further studies with larger numbers of patients are needed. Clinical trial registered with https://jrct.mhlw.go.jp/en-top (jRCTs031190008).
- 1 August 2025
- Published by Oxford University Press (OUP) in Annals of the American Thoracic Society
- Vol. 22 (8) , 1183-1192
Open AccessIntermittent Versus Daily Therapy for Noncavitary Mycobacterium avium Complex Pulmonary Disease: An Open-Label Randomized Trial
Rationale: Patients with noncavitary nodular bronchiectatic (NB) Mycobacterium avium complex pulmonary disease (MAC-PD) are treated intermittently three times per week, although no randomized controlled trials have been conducted comparing three times weekly with daily therapy. Objectives: To assess the tolerability, safety, and efficacy of intermittent versus daily treatment in patients with previously untreated noncavitary NB MAC-PD. Methods: In an open-label study, patients were randomly assigned to the intermittent therapy group receiving clarithromycin 1,000 mg, rifampicin 600 mg, and ethambutol 25 mg/kg (maximum 1,000 mg) three days per week or the daily therapy group receiving clarithromycin 800 mg, rifampicin 450 mg, and ethambutol 15 mg/kg (maximum 750 mg) daily for 1 year. The primary endpoint was the proportion of patients requiring modification of the initial treatment regimen. Results: Twenty-one Japanese hospitals participated in the study, enrolling 141 patients between May 2019 and December 2021. The full analysis set included 138 participants (intermittent therapy = 70; daily therapy = 68). There were no significant differences between the intermittent and daily therapy groups in terms of the regimen modification rate (20.0% [14 of 70] vs. 33.8% [23 of 68]; adjusted odds ratio, 0.48; 95% confidence interval, 0.22 to 1.05; P = 0.06) or culture conversion (70.3% vs. 80.0%; P = 0.53), time to culture conversion (28.0 vs. 28.5 d; P = 0.89), improvement in chest CT findings (60.9% vs. 71.0%; P = 0.30), or clarithromycin resistance development (1.4% vs. 0%; P = 1.00). Elevated aspartate aminotransferase (16.9% vs. 41.2%; P = 0.003) and alanine aminotransferase (18.3% vs. 44.1%; P = 0.002) were more common in the daily treatment group, whereas elevated bilirubin (11.3% vs. 1.5%; P = 0.04) and dysgeusia (14.1% vs. 1.5%; P = 0.01) were more common in the intermittent treatment group. The daily treatment group exhibited a greater absolute change in the 36-Item Short Form Health Survey physical aspect score (−2.5 points) than the intermittent treatment group (2.1 points) (P = 0.01). Conclusions: Intermittent treatment was not significantly better tolerated than daily treatment for noncavitary NB MAC-PD. However, further studies with larger numbers of patients are needed. Clinical trial registered with https://jrct.mhlw.go.jp/en-top (jRCTs031190008).
- 1 September 2021
- Published by Elsevier in The American Journal of the Medical Sciences
- Vol. 362 (3) , 321-323
Nivolumab-Induced Polymyalgia Rheumatica in a Patient with Lung Adenocarcinoma
- 1 September 2021
- Published by Elsevier in The American Journal of the Medical Sciences
- Vol. 362 (3) , 321-323
Nivolumab-Induced Polymyalgia Rheumatica in a Patient with Lung Adenocarcinoma